Diabetic retinopathy,Retinal vein occlusion,Age-related macular degeneration,Other retinopathy
Conditions
Interventions
120 people 240 eyes Intervention content for individual subjects:Instill Midorin P and Neocinedin before using Angiography Dose:0.2ml frequency:Once
Sponsors
National Hospital Organization Kyushu Medical Center Ophthalmology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Those who fully understand this research plan and can give their consent (2) Those who are 20 years old or older at the time of obtaining consent. (3) Those with diabetic retinopathy, branch retinal vein occlusion, age-related macular degeneration or other retinopathy
Exclusion criteria
Exclusion criteria: (1) Those who have a history of hypersensitivity to mydriatic agents, those who have a predisposition to increased intraocular pressure such as angle-closure glaucoma and narrow-angle angle, and those who have a history of increased blood pressure or palpitation due to mydriatic agents.Someone (2) Those who have a shallow anterior chamber by slit lamp microscopy (3) Those who are judged to be difficult to take due to cataract by slit lamp microscopy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of retinal structure, retinal blood vessel shape, and retinal blood vessel perfusion by comparison with conventional fluorescence fundus angiography and OCT. Specifically, the network thickness, vascular density, area of foveal avascular field and non-perfused area, visibility of retinal capillary aneurysm and retinal / choroidal neovascularization will be examined. | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between Primary endpoint and the following clinical findings.Clinical findings: Information on age, gender, examination history and medical history (maximum corrected visual acuity, intraocular pressure, slit lamp microscopy, inversion ophthalmoscope examination, fundus photography, static quantitative visual field examination, conventional OCT analysis data, retinal electrocardiographyFigure, blood pressure, blood test) | — |
Countries
Japan
Contacts
Public Contactshintaro nakao
National Hospital Organization Kyushu Medical Center Ophthalmology
Outcome results
None listed